Gene · 10544
Papers2,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Space microgravity increases expression of genes associated with proliferation and differentiation in human cardiac spheres. | NPJ Microgravity | 2023 | 38071377 | PubTator, text mining | PubMed |
| AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells. | Cell Rep Methods | 2023 | 38070507 | PubTator, text mining | PubMed |
| Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success. | Cancers (Basel) | 2023 | 38067396 | PubTator, text mining | PubMed |
| Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance. | Cells | 2023 | 38067114 | PubTator, text mining | PubMed |
| Different PfEMP1-expressing Plasmodium falciparum variants induce divergent endothelial transcriptional responses during co-culture. | PLoS One | 2023 | 38033133 | PubTator, text mining | PubMed |
| An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series. | J Inflamm Res | 2023 | 38026243 | PubTator, text mining | PubMed |
| The pathogenesis and potential therapeutic targets in sepsis. | MedComm (2020) | 2023 | 38020710 | PubTator, text mining | PubMed |
| Organotypic heterogeneity in microvascular endothelial cell responses in sepsis-a molecular treasure trove and pharmacological Gordian knot. | Front Med (Lausanne) | 2023 | 38020105 | PubTator, text mining | PubMed |
| Computational analysis of the functional and structural impact of the most deleterious missense mutations in the human Protein C. | PLoS One | 2023 | 38015884 | PubTator, text mining | PubMed |
| Core-dependent post-translational modifications guide the biosynthesis of a new class of hypermodified peptides. | Nat Commun | 2023 | 38007494 | PubTator, text mining | PubMed |
| Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature. | Discov Oncol | 2023 | 37999824 | PubTator, text mining | PubMed |
| Molecular Linkage between Immune System Disorders and Atherosclerosis. | Curr Issues Mol Biol | 2023 | 37998729 | PubTator, text mining | PubMed |
| Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis. | Immunity | 2023 | 37967531 | PubTator, text mining | PubMed |
| MiRNAs and Their Role in Venous Thromboembolic Complications. | Diagnostics (Basel) | 2023 | 37958279 | PubTator, text mining | PubMed |
| Chemokines, molecular drivers of thromboinflammation and immunothrombosis. | Front Immunol | 2023 | 37954596 | PubTator, text mining | PubMed |
| Low levels of peripheral blood activated and senescent T cells characterize people with HIV-1-associated neurocognitive disorders. | Front Immunol | 2023 | 37954593 | PubTator, text mining | PubMed |
| Lactoferrin and Activated Protein C: Potential Role in Prevention of Cancer Progression and Recurrence. | Int J Mol Cell Med | 2023 | 37942258 | PubTator, text mining | PubMed |
| How effective is extracorporeal life support for patients with out-of-hospital cardiac arrest initiated at the emergency department? A systematic review and meta-analysis. | PLoS One | 2023 | 37934739 | PubTator, text mining | PubMed |
| Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance. | Oncogenesis | 2023 | 37932309 | PubTator, text mining | PubMed |
| Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning. | Alzheimers Res Ther | 2023 | 37925455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10544/papers?page=9